scispace - formally typeset
G

Gary M. Brittenham

Researcher at Columbia University

Publications -  262
Citations -  17412

Gary M. Brittenham is an academic researcher from Columbia University. The author has contributed to research in topics: Anemia & Iron deficiency. The author has an hindex of 62, co-authored 252 publications receiving 16156 citations. Previous affiliations of Gary M. Brittenham include Columbia University Medical Center & MetroHealth.

Papers
More filters
Journal ArticleDOI

Iron-chelating therapy and the treatment of thalassemia

Nancy F. Olivieri, +1 more
- 01 Feb 1997 - 
TL;DR: The toxicity of this agent mandates a careful evaluation of the balance between risk and benefit of deferiprone in patients with thalassemia, in most of whom long-term deferoxamine is safe and efficacious therapy.
Journal ArticleDOI

Biomarkers of Nutrition for Development (BOND)-Iron Review.

TL;DR: A full appreciation of folate's history as a public health issue, its biology, and an overview of available biomarkers and their interpretation across a range of clinical and population-based uses are provided.
Journal ArticleDOI

Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major.

TL;DR: The early use of deferoxamine in an amount proportional to the transfusional iron load reduces the body iron burden and helps protect against diabetes mellitus, cardiac disease, and early death in patients with thalassemia major.
Journal ArticleDOI

Hepatic Iron Concentration and Total Body Iron Stores in Thalassemia Major

TL;DR: The hepatic iron concentration is a reliable indicator of total body iron stores in patients with thalassemia major and in patientsWith transfusion-related iron overload, repeated determinations of the hepaticIron concentration can provide a quantitative means of measuring the long-term iron balance.
Journal ArticleDOI

Experimental liver cirrhosis induced by alcohol and iron.

TL;DR: Evidence is provided for a critical role of iron and iron-catalyzed oxidant stress in progression of alcoholic liver disease by intragastrically infused rats with or without ethanol to determine if alcoholic liver fibrogenesis is exacerbated by dietary iron supplementation.